These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14734473)

  • 61. CIP2A expression is increased in prostate cancer.
    Vaarala MH; Väisänen MR; Ristimäki A
    J Exp Clin Cancer Res; 2010 Oct; 29(1):136. PubMed ID: 20964854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
    Koochekpour S; Marlowe T; Singh KK; Attwood K; Chandra D
    PLoS One; 2013; 8(9):e74688. PubMed ID: 24086362
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.
    Zenner ML; Helou YB; Deaton RJ; Sverdlov M; Wang H; Kajdacsy-Balla A; Macias V; Voisine C; Murray M; Abdulkadir SA; Murphy AB; Nonn L
    Prostate; 2022 Feb; 82(3):306-313. PubMed ID: 34855273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
    Bandini M; Marchioni M; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Shariat SF; Montorsi F; Saad F; Briganti A; Tilki D; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):449-456. PubMed ID: 29249688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease.
    Schapira MM; McAuliffe TL; Nattinger AB
    Med Care; 1995 Nov; 33(11):1079-88. PubMed ID: 7475418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.
    Hu SY; Liu T; Liu ZZ; Ledet E; Velasco-Gonzalez C; Mandal DM; Koochekpour S
    Asian J Androl; 2010 May; 12(3):336-43. PubMed ID: 20173765
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina.
    Ellis SD; Blackard B; Carpenter WR; Mishel M; Chen RC; Godley PA; Mohler JL; Bensen JT
    Cancer; 2013 Jun; 119(12):2282-90. PubMed ID: 23575751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.
    Mao XY; Fan CF; Wei J; Liu C; Zheng HC; Yao F; Jin F
    Tumour Biol; 2011 Dec; 32(6):1271-6. PubMed ID: 21909787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.
    Ifere GO; Equan A; Gordon K; Nagappan P; Igietseme JU; Ananaba GA
    Cancer Epidemiol; 2010 Aug; 34(4):461-71. PubMed ID: 20466611
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Racial differences in prostate cancer treatment outcomes: a systematic review.
    Peters N; Armstrong K
    Cancer Nurs; 2005; 28(2):108-18. PubMed ID: 15815180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.
    Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR
    Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictors of Gleason score upgrading in a large African-American population.
    Vora A; Large T; Aronica J; Haynes S; Harbin A; Marchalik D; Nissim H; Lynch J; Bandi G; McGeagh K; Kowalczyk K; Ghasemian R; Venkatesan K; Verghese M; Hwang J
    Int Urol Nephrol; 2013 Oct; 45(5):1257-62. PubMed ID: 23864415
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens.
    Tiguert R; Gheiler EL; Tefilli MV; Banerjee M; Grignon DJ; Sakr W; Wood DP; Powell IJ; Pontes JE
    Prostate; 1998 Dec; 37(4):230-5. PubMed ID: 9831219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
    Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
    Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.
    Khan S; Cai J; Nielsen ME; Troester MA; Mohler JL; Fontham ETH; Farnan L; Drake BF; Olshan AF; Bensen JT
    Cancer Causes Control; 2018 Nov; 29(11):1143-1150. PubMed ID: 30267174
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.
    Powell IJ; Dey J; Dudley A; Pontes JE; Cher ML; Sakr W; Grignon DJ; Wood DP
    Urology; 2002 Jun; 59(6):907-12. PubMed ID: 12031379
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of brachytherapy for prostate cancer in African Americans compared with Caucasians.
    Barrett WL; Kassing WM; Shirazi R
    Brachytherapy; 2004; 3(1):30-3. PubMed ID: 15110311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs.
    Slade AN; Dahman B; Chang MG
    Brachytherapy; 2020; 19(1):6-12. PubMed ID: 31611160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.